We are live on ! Find out more
LBPH

Longboard Pharmaceuticals, Inc. Common Stock

Delisted

LBPH was delisted on the 29th of November, 2024.

Fund managers haven’t disclosed any holdings of LBPH yet.

LBPH Hedge Fund Activity: Q4 2024 in Review

0 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Longboard Pharmaceuticals, Inc. Common Stock (LBPH) for Q4 2024, worth a combined $0 — down 100% from $1.33B a quarter earlier.

Sellers outnumbered buyers: 124 funds closed out of LBPH and 0 opened new positions — a net loss of 124 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $145M sold.

  • 0 institutional investors held Longboard Pharmaceuticals, Inc. Common Stock (LBPH) as of Q4 2024, down from 125 in Q3 2024.
  • Funds reported $0 of Longboard Pharmaceuticals, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Longboard Pharmaceuticals, Inc. Common Stock positions in Q4 2024 and 124 closed out, a net change of -124 holders.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock seller in Q4 2024 was Fidelity Investments, an estimated $145M sold.

Based on aggregated 13F filings for Q4 2024.